Form 4 for OLMA Olema Pharmaceuticals, Inc.
Accepted 2024-12-11 00:00:00 ET · period of report 2024-12-09 · accession 0001415889-24-029024 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-12-11 | 2024-12-09 | OLMA | Bohen Sean | Pres AND CEO, Dir | A - Grant | $0.00 | +204.8K | 351.2K | +140% | $0 | |
| M | 2024-12-11 | 2024-12-10+ | OLMA | Bohen Sean | Pres AND CEO, Dir | S - Sale | $9.01 | -109.5K | 298.8K | -27% | -$986.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-09 | A | A | 204,750 | $0.00 | 351,164 | D | — | — | (F1) On November 11, 2022, the Reporting Person was granted certain performance restricted stock units ("PRSUs") for 315,000 shares, which were subject to vesting upon certification by the Compensation Committee of the Company's achievement of two different performance milestones. 35% of the award previously vested on November 20, 2023. On December 9, 2024, the Compensation Committee certified that the remaining 65% of the award vested based on achievement of certain performance criteria. (F2) Includes 1,489 shares acquired under the Issuer's Employee Stock Purchase Plan on June 30, 2024. |
| 2 | Common | Common Stock | 2024-12-11 | S | D | 1,267 | $9.39 | 241,662 | D | — | — | (F6) The weighted average sale price for the transaction reported was $9.39, and the range of prices was between $9.31 and $9.74. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. |
| 3 | Common | Common Stock | 2024-12-11 | S | D | 55,907 | $8.66 | 242,929 | D | — | — | (F5) The weighted average sale price for the transaction reported was $8.66, and the range of prices was between $8.22 and $9.21. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. |
| 4 | Common | Common Stock | 2024-12-10 | S | D | 52,328 | $9.37 | 298,836 | D | — | — | (F4) The weighted average sale price for the transaction reported was $9.37, and the range of prices was between $8.87 and $9.70. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. |